SCHEMBL286176

SCHEMBL286176

Cc1onc(-c2ccc(F)cn2)c1CCc1ncc(C(=O)OCC(N)=O)s1

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 19/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL285805 0.88 GABRA5 (0.58) GABRA5
SCHEMBL285782 0.87 GABRA5 (0.47) GABRA5
SCHEMBL285946 0.86 GABRA5 (0.47) GABRA5
SCHEMBL286101 0.85 GABRA5 (0.55) GABRA5
SCHEMBL285575 0.84 GABRA5 (0.51) GABRA5
SCHEMBL291608 0.82 GABRA5 (0.49) GABRA5
SCHEMBL286265 0.81 GABRA5 (0.58) GABRA5
SCHEMBL286049 0.80 GABRA5 (0.43) GABRA5
SCHEMBL292204 0.79 GABRA5 (0.48) GABRA5
SCHEMBL285576 0.79 GABRA5 (0.51) GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2427459-A1 ISOXAZOLE-THIAZOLE DERIVATIVES AS GABA A RECEPTOR INVERSE AGONISTS FOR USE IN THE TREATMENT OF COGNITIVE DISORDERS F. Hoffmann-La Roche AG (CH) 2012-03-14 EP disclosed